S100-BETA PROMOTES THE EXTENSION OF MICROTUBULE-ASSOCIATED PROTEIN2 (MAP2)-IMMUNOREACTIVE NEURITES RETRACTED AFTER COLCHICINE TREATMENT IN RAT SPINAL-CORD CULTURE

Citation
M. Nishi et al., S100-BETA PROMOTES THE EXTENSION OF MICROTUBULE-ASSOCIATED PROTEIN2 (MAP2)-IMMUNOREACTIVE NEURITES RETRACTED AFTER COLCHICINE TREATMENT IN RAT SPINAL-CORD CULTURE, Neuroscience letters, 229(3), 1997, pp. 212-214
Citations number
16
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03043940
Volume
229
Issue
3
Year of publication
1997
Pages
212 - 214
Database
ISI
SICI code
0304-3940(1997)229:3<212:SPTEOM>2.0.ZU;2-M
Abstract
S100 beta, a glial derived calcium-binding protein with neurotrophic a ctivity in the central nervous system, stimulates neurite extension of fetal raphe. cortex, spinal cord, and dorsal root ganglion neurons. T he effects of S100 beta on neurite length and microtubule associated p rotein2 (MAP2) immunoreactivity (IR) after microtubule disruption with colchicine were investigated in primary rat spinal cord culture. The incubation with S100 beta (20 ng/ml) for 3 h after exposure to colchic ine (10(-6) M) for 30 min altered the distribution of MAP2-IR. The len gth of MAP2-IR neurites increased by 65% compared to that in colchicin e treatment alone. MAP2-IR intensity in the cell body was reduced by 2 6% compared to that in colchicine treatment alone. These results indic ate that neurites shrink when the microtubular cytoskeletal system is disrupted and S100 beta rapidly promotes re-assembly and/or stabilizat ion. (C) 1997 Elsevier Science ireland Ltd.